Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
23. Dezember 2024 07:30 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
IMAC Holdings, Inc. Enters 2022 with Improved Balance Sheet
19. Januar 2022 08:30 ET
|
IMAC Holdings, Inc.
Company reduces significant debt in 2021 BRENTWOOD, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical...
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
11. Februar 2021 08:45 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...